VerabreichungStudienlage & Dosis

Top-Studien zu Verabreichung

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

1. 01

   A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.

   Neuropsychopharmacology·2002RCT30 einflussreiche Zitationen

   Acamprosate and naltrexone have each demonstrated safety and efficacy for alcohol dependence in placebo-controlled clinical trials. There is scientific and clinical interest in evaluating these drugs in combination, given their high…

2. 02

   Comparative pharmacokinetic analysis of curcumin and curcumin O-glucuronide through curcumin nano-gel-based delivery system using liquid chromatogram tandem mass spectrometry.

   Pak J Pharm Sci·2026Study

   <h4>Background</h4>Curcumin exhibits limited oral bioavailability owing to its poor solubility and rapid metabolism.<h4>Objectives</h4>To develop a novel curcumin nano-gel (CNG) and evaluate its pharmacokinetics following oral and rectal…

3. 03

   Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

   Critical care medicine·2018

   Objective: To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU. Design: Thirty-two international experts, four methodologists, and four critical…

4. 04

   CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

   MMWR Recommendations and Reports·2016

   This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or…

5. 05

   Pharmacokinetics of a novel formulation of ivermectin after administration to goats

   American Journal of Veterinary Research·2006

   <h4>Objective</h4>To evaluate the pharmacokinetics of a novel commercial formulation of ivermectin after administration to goats.<h4>Animals</h4>6 healthy adult goats.<h4>Procedure</h4>Ivermectin (200 microg/kg) was initially administered…

6. 06

   EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

   Annals of the Rheumatic Diseases·2013

   In this article, the 2010 European League against Rheumatism (EULAR) recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological disease-modifying antirheumatic drugs (sDMARDs and bDMARDs, respectively)…

7. 07

   EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.

   Annals of the rheumatic diseases·2023

   <h4>Objectives</h4>To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field.<h4>Methods</h4>An international task force was formed and solicited three…

8. 08

   CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.

   MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports·2022·n=14

   This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016…